Company: INMB
Filing Date: 2025-06-10
Form Type: 8-K
Source: 0001213900-25-053051
Chunk: 3

Company: Inmune Bio, Inc.
Filing Date: 2025-06-10
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press Release, dated June 10, 2025                                           
 ────────────────────────────────────────────────────────────────────────────────────────────────
         10.1      Second Amended and Restated INmune Bio Inc. 2021 Stock Incentive Plan.       
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           INMUNE BIO INC.                               
  Date: June 10, 2025      By:                  /s/ David Moss           
                                                David Moss               
                                                Chief Financial Officer